1. “Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021”
by Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, Sabine Allam, Morgan Bou Zerdan, Marita Yaghi, Nadeem Bilani, Rola Jaafar and Zeina Nahleh
Cancers 2022, 14(5), 1253; https://doi.org/10.3390/cancers14051253
Available online: https://www.mdpi.com/2072-6694/14/5/1253

2. “MMP9: A Tough Target for Targeted Therapy for Cancer”
by Katarzyna Augoff, Anita Hryniewicz-Jankowska, Renata Tabola and Kamilla Stach
Cancers 2022, 14(7), 1847; https://doi.org/10.3390/cancers14071847
Available online: https://www.mdpi.com/2072-6694/14/7/1847

3. “Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers”
by Lindsey Carlsen, Kelsey E. Huntington and Wafik S. El-Deiry
Cancers 2022, 14(4), 1028; https://doi.org/10.3390/cancers14041028
Available online: https://www.mdpi.com/2072-6694/14/4/1028

4. “Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic”
by Ana Isabel Fraguas-Sánchez, Irene Lozza and Ana Isabel Torres-Suárez
Cancers 2022, 14(5), 1198; https://doi.org/10.3390/cancers14051198
Available online: https://www.mdpi.com/2072-6694/14/5/1198

5. “The Renaissance of Cyclin Dependent Kinase Inhibitors”
by Tobias Ettl, Daniela Schulz and Richard Josef Bauer
Cancers 2022, 14(2), 293; https://doi.org/10.3390/cancers14020293
Available online: https://www.mdpi.com/2072-6694/14/2/293

6. “Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms”
by Daisuke Takayanagi, Hourin Cho, Erika Machida, Atsushi Kawamura, Atsuo Takashima, Satoshi Wada, Takuya Tsunoda, Takashi Kohno and Kouya Shiraishi
Cancers 2022, 14(5), 1119; https://doi.org/10.3390/cancers14051119
Available online: https://www.mdpi.com/2072-6694/14/5/1119

7. “PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities”
by Hao-Wen Sim, Evanthia Galanis and Mustafa Khasraw
Cancers 2022, 14(4), 1003; https://doi.org/10.3390/cancers14041003
Available online: https://www.mdpi.com/2072-6694/14/4/1003

8. “Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2”
by Swati Misri, Kirti Kaul, Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Martin P. Barr, Dinesh K. Ahirwar and Ramesh K. Ganju
Cancers 2022, 14(5), 1181; https://doi.org/10.3390/cancers14051181
Available online: https://www.mdpi.com/2072-6694/14/5/1181

9. “Early Response Prediction of Multiparametric Functional MRI and 18F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation”
by Roland M. Martens, Thomas Koopman, Cristina Lavini, Tim van de Brug, Gerben J. C. Zwezerijnen, J. Tim Marcus, Marije R. Vergeer, C. René Leemans, Remco de Bree, Pim de Graaf et al.
Cancers 2022, 14(1), 216; https://doi.org/10.3390/cancers14010216
Available online: https://www.mdpi.com/2072-6694/14/1/216

10. “Knowns and Unknowns about CAR-T Cell Dysfunction”
by Aleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Aygul Rakhmatullina, Alexey Petukhov, Regina Miftakhova, Albert Rizvanov and Emil Bulatov
Cancers 2022, 14(4), 1078; https://doi.org/10.3390/cancers14041078
Available online: https://www.mdpi.com/2072-6694/14/4/1078